XML 22 R12.htm IDEA: XBRL DOCUMENT v3.25.3

FAIR VALUE MEASUREMENT

9 Months Ended

Sep. 30, 2025

Investments, All Other Investments [Abstract]

FAIR VALUE MEASUREMENT

NOTE 5 – FAIR VALUE MEASUREMENT

On September 30, 2025 and December 31, 2024, the Company estimated the aggregate fair value of warrants that are accounted for as warrant liabilities to be $1,968,315 and $2,520,851, respectively, using the Black-Scholes option price model (Level 3 inputs). The Company recognized a gain on the change in fair value of these warrant liabilities of $612,064 and $552,536 for the three and nine months ended September 30, 2025, respectively. The Company recognized a gain (loss) on the change in fair value of these warrant liabilities of $1,036,464 and ($837,466) for the three and nine months ended September 30, 2024, respectively. The following table shows the detail of the valuation assumptions used as of September 30, 2025:

SCHEDULE OF FAIR VALUE VALUATION ASSUMPTIONS 

		September 30, 2025
Risk free interest rate			3.63%-3.68%
Expected term (years)			1.11 - 3.36
Expected volatility			71% - 95%
Expected dividends			0.00%

SCHEDULE OF FAIR VALUE MEASURED ON RECURRING BASIS 

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis during the three months ended September 30, 2025 and three months ended September 30, 2024:

		2025				2024
		For the Three Months Ended September 30,
		2025				2024
Balance, July 1,		$	2,580,379			$	4,491,969
Change in fair value of warrant liability			(612,064	)			(1,036,464	)
Balance, September 30,		$	1,968,315			$	3,455,505

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis during the nine months ended September 30, 2025 and nine months ended September 30, 2024:

		2025				2024
		For the Nine Months ended September 30,
		2025				2024
Balance, January 1,		$	2,520,851			$	2,618,039
Change in fair value of warrant liability			(552,536	)			837,466
Balance, September 30,		$	1,968,315			$	3,455,505

Assets and liabilities measured at fair value on a recurring basis are as follows:

SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS 

		Fair value measurements at reporting date using:
		Quoted prices in active markets for identical liabilities (Level 1)				Significant other observable inputs (Level 2)				Significant unobservable inputs (Level 3)				Total Fair Value
Assets:
Marketable securities as of September 30, 2025		$	3,887,383			$	-			$	-			$	3,887,383
Marketable securities as of December 31, 2024		$	10,184,701			$	-			$	-			$	10,184,701
Liabilities:
Warrant liabilities as of September 30, 2025		$	-			$	-			$	1,968,315			$	1,968,315
Warrant liabilities as of December 31, 2024		$	-			$	-			$	2,520,851			$	2,520,851

X

- Definition

The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/825/tableOfContent

+ Details

Name:	us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration